Anureet(Cheema)CopelandMD

PubMed

• Association of self-directed walking with toxicity moderation during chemotherapy for the treatment of early breast cancer.
  Nyrop, K., Page, A., Deal, A., Wagoner, C., Kelly, E., Wood, W., Muss, H., Kimmick, G., Copeland, A., Speca, J.> ;Supportive Care in Cancer. 2023 Dec 28
• 2 citations
  A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, accep...
  Zev M Nakamura, Allison M Deal, Eliza M Park, Kate E Stanton, Yesy E Lopez, Laura J Quillen, Erin O'Hare Kelly, Hillary M Heiling, Kirsten A Nyrop, Emily M Ray, E Clai...> ;Cancer Medicine. 2023 Apr 1
• 2 citations
  Collaborative care for depression and anxiety in the bone marrow transplant population: A pilot feasibility study
  Anureet C. Copeland, Xianming Tan, Rebekah P. Nash, Emily G. Holmes, Janell Markey, Thomas C. Shea, William A. Wood, Eliza M. Park> ;Psycho-Oncology. 2021 Jan 1
• 1 citations
  The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors.
  Anureet C. Copeland, Matthew C. Foster, Benyam Muluneh, James G. Xenakis, Anastasia Ivanova, Olga Frankfurt, Monique Clayton, Anderson Black, Barbara Rapchak, Robert S...> ;Leukemia & Lymphoma. 2019 Feb 18
• 2 citations
  Dual HER2-Targeting in the Adjuvant Setting: Where We Have Been and Where We Are Going.
  Anureet C Copeland, Carey K. Anders> ;Oncology. 2018 Oct 17
• Join now to see all